Intranasal Splint Approval by HSA featuring Sporogenics
We are thrilled to announce that our 1st anti-adhesion medical device, the SPORONGE Intranasal Splint, has received approval from Singapore’s Health Science Authority (HSA)! This milestone is a testament to our commitment to enhancing patient care and advancing medical technology. The SPORONGE Intranasal Splint is designed to minimize bleeding and edema and prevent adhesions between the septum and the nasal cavity. Utilizing our proprietary immunomodulating biomaterials from Sporogenics, this device represents a significant advancement in postoperative care for nasal surgeries.
